All manuscripts
Scientific Posters G-Rex®500M-CS

G-Rex® and Heracell Vios Incubators and Cross Contamination Prevention

Share
1 page G-Rex and Heracell Vios Incubators and Cross Contamination Prevention

Overview

For Cell and Gene Modified Cell Therapy (CGT) manufacturing, a robust contamination control strategy (CCS) is necessary to ensure compliance with current Good Manufacturing Practices (cGMP). A successful CCS helps ensure safety, purity, efficacy, and quality of a CGT product. CGT manufacturers should implement Closed Systems wherever possible and employ equipment that maintains a stable, clean environment with advanced monitoring. We show that Closed System G-Rex® combined with Thermo ScientificTM HeracellTM ViosTM CR carbon dioxide (CO2) incubators enable simplified parallel processing capabilities and significantly reduced contamination risks in a highly efficient production.

What this paper found

Closed System G-Rex® bioreactors held their sterile fluid path intact through at least fourteen days of full immersion in a challenge solution of Brevundimonas diminuta, a 0.3 to 0.6 micrometre motile gram-negative indicator organism, with no bacterial growth recovered from nutrient broth sampled from the test vessels. G-Rex® membrane material also passed viral penetration testing to ASTM F1671, with 32 test articles pressurised to 2.0 psig against a Phi-X174 bacteriophage suspension of at least 1.0 x 10^6/mL. Ten G-Rex® 500M-CS bioreactors incubated together in a Heracell Vios CR CO2 incubator still allowed recovery of temperature, CO2 and humidity within 10 minutes, uniformity of +/- 0.3 C, ISO Class 5 in-chamber air and 12-log sterility assurance.

Study details

Authors
Mary Kay Bates, Dan Fick, Jürgen Schneider, Dan Welch, Lindsey Low
Institution
Thermo Fisher Scientific, Robert Bosch Strasse 1, Langenselbold, Germany · Wilson Wolf Manufacturing LLC, 2100 Old Highway 8 NW, St. Paul, MN · ScaleReady LLC, 2100 Old Highway 8 NW, St. Paul, MN
G-Rex® model(s)
G-Rex®500M-CS
Application area
Other
Study phase
Preclinical

How G-Rex® was used

Closed System G-Rex® bioreactors were used as the test article rather than as a culture vessel, to substantiate closed-system and sterile fluid path claims for T cell and NK cell manufacturing. Whole bioreactors were fully immersed in a bacterial challenge solution and incubated for fourteen days for microbial ingress testing based on ASTM E-3251, after which broth from each vessel was plated in triplicate. Separately, G-Rex® gas-permeable membrane material was mounted in a test apparatus for bacteriophage penetration testing to ASTM F1671. For incubator qualification, ten G-Rex® 500M-CS bioreactors were placed in a single Heracell Vios CR CO2 incubator chamber, four of them flanking the sensors on the middle shelf.

Explore related

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →